FY2027 Earnings Estimate for QIPT Issued By Leede Financial

Quipt Home Medical Corp. (NASDAQ:QIPT) – Equities research analysts at Leede Financial issued their FY2027 earnings per share estimates for Quipt Home Medical in a research note issued to investors on Tuesday, February 11th. Leede Financial analyst D. Loe forecasts that the company will post earnings of ($0.10) per share for the year. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.

Quipt Home Medical Stock Performance

Shares of Quipt Home Medical stock opened at $2.90 on Thursday. The business has a fifty day simple moving average of $2.89 and a two-hundred day simple moving average of $2.86. The firm has a market capitalization of $124.92 million, a P/E ratio of -19.24 and a beta of 0.57. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.73. Quipt Home Medical has a 12 month low of $2.30 and a 12 month high of $4.98.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Insider Transactions at Quipt Home Medical

In other news, VP Patrick Dennis Gamble purchased 17,000 shares of Quipt Home Medical stock in a transaction that occurred on Thursday, December 26th. The stock was bought at an average price of $2.45 per share, with a total value of $41,650.00. Following the completion of the transaction, the vice president now directly owns 40,057 shares of the company’s stock, valued at approximately $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 13.40% of the company’s stock.

Hedge Funds Weigh In On Quipt Home Medical

A number of hedge funds and other institutional investors have recently modified their holdings of QIPT. SG Americas Securities LLC bought a new position in shares of Quipt Home Medical during the 3rd quarter valued at about $44,000. Atom Investors LP purchased a new stake in shares of Quipt Home Medical during the 3rd quarter worth approximately $51,000. XTX Topco Ltd purchased a new position in Quipt Home Medical in the third quarter worth about $54,000. Wells Fargo & Company MN lifted its position in Quipt Home Medical by 30.9% in the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after buying an additional 5,625 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Quipt Home Medical by 68.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock worth $89,000 after acquiring an additional 12,383 shares during the last quarter. Institutional investors own 42.85% of the company’s stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.